Anteris Technologies Global (ASX:AVR) was admitted to the official list of the Australian Securities Exchange Monday, according to a same-day filing with the Australian bourse.
The move was made following parent biotechnology firm Anteris Group's decision to re-domicile in the US from Australia.
Anteris Technologies Global expects its CHESS depositary interest will start quotation on Dec. 17, the filing said.
It expects to raise $88.8 million via its initial public offer on the Nasdaq which is expected to close on Monday, the filing added.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。